SPHERE POWER INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8,470 KRW | -3.64% |
|
-10.18% | -16.63% |
| Sales 2022 | 26.58B 19.19M | Sales 2023 | 37.25B 26.9M | Capitalization | 119B 86.03M |
|---|---|---|---|---|---|
| Net income 2022 | -5.56B -4.02M | Net income 2023 | -24.37B -17.59M | EV / Sales 2022 | 2.65 x |
| Net Debt 2022 | 25.96B 18.74M | Net Debt 2023 | 7.38B 5.33M | EV / Sales 2023 | 3.4 x |
| P/E ratio 2022 |
-8.01
x | P/E ratio 2023 |
-3.94
x | Employees | 67 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 88.11% |
More Fundamentals
* Assessed data
More news
| 1 day | -3.64% | ||
| 1 week | -10.18% | ||
| 1 month | -9.22% | ||
| 3 months | -6.62% | ||
| 6 months | -20.77% | ||
| Current year | -16.63% |
1 week
8 420.00
9 400.00
1 month
8 290.0010 380.00
Current year
8 290.0014 040.00
1 year
4 350.0014 040.00
3 years
3 290.0021 250.00
5 years
3 290.0026 750.00
10 years
3 290.0077 250.00
| Managers | Title | Age | Since |
|---|---|---|---|
Byung-Soon Park
CEO | Chief Executive Officer | 54 | - |
Eun-Wook Choi
CEO | Chief Executive Officer | 53 | - |
Dong-Ju Kim
AUD | Comptroller/Controller/Auditor | 53 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Eun-Wook Choi
CEO | Chief Executive Officer | 53 | - |
Byung-Soon Park
CEO | Chief Executive Officer | 54 | - |
Young-Tae Kang
BRD | Director/Board Member | 59 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-31 | 8,470 | -3.64% | 38,997 |
| 24-05-30 | 8,790 | -1.12% | 23,528 |
| 24-05-29 | 8,890 | -4.92% | 24,077 |
| 24-05-28 | 9,350 | +0.54% | 55,876 |
| 24-05-27 | 9,300 | -1.38% | 65,104 |
End-of-day quote Korea S.E., May 30, 2024
More quotes
Sphere Power Inc is a Korea-based company engaged in the business of manufacturing stem cell culture fluid cosmetics. The Company operates through two segments. The Household Health Business segment engages in weeding and sales of wet wipes. The Bio Business segment is engaged in the research and development of pharmaceuticals, cosmetics, and health functional foods. In addition, this segment is engaged in the bio business, such as the development of inflammatory bowel disease (IBD) treatment using microbiome exosomes, intestinal health functional food, and anticancer treatment.
Sector
Personal Products
Calendar
2024-08-12
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -16.63% | 75.94M | |
| +0.32% | 262B | |
| +18.76% | 20.37B | |
| -.--% | 19.29B | |
| +16.91% | 12.64B | |
| -16.59% | 8.94B | |
| +33.93% | 8.62B | |
| +9.55% | 5.93B | |
| -12.08% | 3.92B | |
| -16.83% | 3.84B |
- Stock Market
- Equities
- A203690 Stock
